Los Angeles, CA — April 21, 2026 — The Terasaki Institute for Biomedical Innovation invites the public to its 2026 Open House on Saturday, April 25, from 10:00 AM to 2:00 PM. Free and open to all ages, the event offers a rare behind-the-scenes and witness firsthand how cutting-edge science is being translated into real-world healthcare solutions.
Los Angeles, CA — April 8, 2026 — The Terasaki Institute for Biomedical Innovation (TIBI) is proud to announce that Principal Investigator Dr. Yangzhi Zhu has published their research in Science Translational Medicine, marking a major milestone for the institute.
Los Angeles, CA — March 30, 2026 — The Terasaki Institute for Biomedical Innovation is proud to announce that Dr. Yangzhi Zhu has been received a prestigious Career Development Award from the American Heart Association (AHA). The award will provide a total of $231,000 over three years to support his research in translational biosensing and organ health assessment.
Los Angeles, CA — March 19, 2026 — The Terasaki Institute for Biomedical Innovation (TIBI) and UCLA Technology Development Group (TDG) announced today a collaboration to program the Advanced Organ and Tissue Repair session during MedTech Day at LABEST, one of Southern California’s premier innovation conferences.
Los Angeles, CA — March 17, 2026 — The Terasaki Institute for Biomedical Innovation (TIBI) is proud to announce that Principal Investigator Dr. Aliesha O’Raw, Co-Founder of OnVagus, has been selected for the 2026 American Cancer Society (ACS) BrightEdge Entrepreneurs (BEE) Program cohort. The BrightEdge Entrepreneurs Program is a competitive program for startups in the cancer diagnostic and therapeutic space, providing mentorship and entrepreneur training alongside early-stage investment support, including a $100,000 SAFE (Simple Agreement for Future Equity) backed by ACS’ BrightEdge Investment Fund.
Los Angeles, CA – March 9, 2026 – The Terasaki Institute for Biomedical Innovation (TIBI) and Keck Graduate Institute (KGI) have announced a new collaborative research partnership designed to accelerate biomedical innovation through joint research programs, faculty collaboration, and expanded student training opportunities.
Los Angeles, CA – February 23, 2026 - Dr. Vadim Jucaud, Principal Investigator and Assistant Professor at the Terasaki Institute, with Co-Principal Investigator Angeles Baquerizo, MD, PhD, FACS, FAASLD have been awarded an NIH R21 research grant to develop a first-of-its-kind organ-on-a-chip platform to study immune rejection in pig-to-human liver transplantation. The project tackles one of the most pressing challenges in modern transplantation medicine: advancing xenotransplantation toward safe and effective clinical use.
Los Angeles, CA – February 18, 2026 - Dr. Vadim Jucaud’s lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates key structural, functional, and immunological features of human liver tissue, enabling the study of liver regeneration and immune-mediated allograft rejection in a physiologically relevant human system.